Abstract:Lingling Yuan, 1 Ting Wang, 1 Jinsheng Duan, 2 Jing Zhou, 1 Na Li, 1 Guizhi Li, 1 Hong Zhou 1 1 Department of Endocrinology, the Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050004, People's Republic of China; 2 Department of Cardiology, the Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050004, People's Republic of China Correspondence: Hong Zhou, Department of Endocrinology, the Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China, Tel +86-15130119625, Email ; Introduction: Cardiac fibrosis is one of the important causes of heart failure and death in diabetic cardiomyopathy (DCM) patients. Circular RNAs (circRNAs) are covalently closed RNA molecules in eukaryotes and have high stability. Their role in myocardial fibrosis with diabetic cardiomyopathy (DCM) remain to be fully elucidated. This study aimed to understand the expression profiles of circRNAs in myocardial fibrosis with DCM, exploring the possible biomarkers and therapeutic targets for DCM. Methods: At 21 weeks of age, db/db mice established the type 2 DCM model measured by echocardiography, and the cardiac tissue was extracted for Hematoxylin–eosin, Masson's trichrome staining, and transmission electron microscopy. Subsequently, the expression profile of circRNAs in myocardial fibrosis of db/db mice was constructed using microarray hybridization and verified by real‐time quantitative polymerase chain reaction. A circRNA–microRNA–messenger RNA coexpression network was constructed, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were done. Results: Compared with normal control mice, db/db mice had 77 upregulated circRNAs and 135 downregulated circRNAs in their chromosomes (fold change ≥ 1.5, P ≤ 0.05). Moreover, the enrichment analysis of circRNA host genes showed that these differentially expressed circRNAs were mainly involved in mitogen-activated protein kinase signaling pathways. CircPHF20L1, circCLASP1, and circSLC8A1 were the key circRNAs. Moreover, circCLASP1/miR-182-5p/Wnt7a, circSLC8A1/miR-29b-1-5p/Col12a1, and most especially circPHF20L1/miR-29a-3p/Col6a2 might be three novel axes in the development of myocardial fibrosis in DCM. Conclusion: The findings will provide some novel circRNAs and molecular pathways for the prevention or clinical treatment of DCM through intervention with specific circRNAs. Keywords: Circular RNAs, expression profile, diabetic cardiomyopathy, cardiac fibrosis, bioinformatic analysis Circular RNAs (circRNAs) are covalently closed RNA molecules in eukaryotes that have high stability; compared with linear RNAs, they are more resistant to exonucleases. 1 CircRNAs mainly act as microRNA (miRNA) sponges, protecting target messenger RNAs from miRNA-dependent degradation; therefore, the target RNA is more actively translated and bound by ribosomes. 2 In patients with diabetes, diabetic cardiomyopathy (DCM) is a specific cardiovascular complication that first manifests as diastolic dysfunction and eventually progresses to refractory heart failure. Myocardial fibrosis is a critical pathological feature of DCM. 3 However, the mechanism involved in the development of myocardial fibrosis in DCM remains unclear. CircRNAs have been reported to play an important role in myocardial fibrosis in DCM. 4–6 A recent study found that diabetes-induced circulation-associated circRNA (DICAR) was downregulated in diabetic mouse hearts and was associated with a negative fibrosis index in DICAR-deficient mice. 7 Tang et al determined that circ_000203 was upregulated in the myocardium from mouse models of type 2 diabetes mellitus (T2DM) and increased the expression of colla2, colla3, and α-smooth muscle actin in cardiac fibroblasts (CFs), thereby exacerbating myocardial fibrosis. 4 In another study, circRNA_010567 was increased in the myocardium from T2DM mice, and knockdown of this circRNA remarkably suppressed myocardial fibrosis via the miR-141/TGF-b1 pathway in angiotensin II (AngII)-induced CFs. 5 CircHIPK3 was found to be upregulated in mouse DCM models induced by streptozotocin, and knockdown of this circRNA could ameliorate myocardial fibrosis and cardiac function in vivo and decrease CF proliferation induced by Ang II via the miR-29b-3p/Col1a1-Col3a1 pathway in vitro. 6 Unfortunately, this study did not perform echocardiography on db/db mice and used Ang II to induce fibroblast fibrosis instead of high glucose (HG), which may not fully reflect the pathogenesis of myocardial fibrosis in HG conditions. Recently, three studies have analyzed the competitive endogenou -Abstract Truncated-

Expression Profiles and Bioinformatic Analysis of Circular RNAs in Db/Db Mice with Cardiac Fibrosis

Analysis of Changes in Circular RNA Expression and Construction of Cerna Networks in Human Dilated Cardiomyopathy.

Effect of circRNA_000203 on fibrotic phenotypes in mouse cardiac fibro-blasts

Hsa_circ_0008360 Sponges Mir-186-5p to Target CCND2 to Modulate High Glucose-Induced Vascular Endothelial Dysfunction.

Circular RNA Circube2k Promotes Hepatic Fibrosis Via Sponging Mir‐149‐5p/tgf‐β2 Axis

Expression Profiling of Circular RNAs and Their Potential Role in Early‑stage Diabetic Cardiomyopathy.

CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts

CircRNA_012164/MicroRNA-9-5p axis mediates cardiac fibrosis in diabetic cardiomyopathy

Expression profiles and bioinformatic analysis of microRNAs in myocardium of diabetic cardiomyopathy mice

Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis

MicroRNA Expression Profiles in a Human Induced Pluripotent Stem Cell‐derived Model of Diabetic Cardiomyopathy

Circular RNA mmu_circ_0005019 inhibits fibrosis of cardiac fibroblasts and reverses electrical remodeling of cardiomyocytes

Abstract P2013: Genomic Identification of Key CircRNAs in Healthy and Dilated Cardiomyopathy Human Heart

Distinct Circulating Expression Profiles of Long Noncoding RNAs in Heart Failure Patients with Ischemic and Nonischemic Dilated Cardiomyopathy.

Circular RNA Expression for Dilated Cardiomyopathy in Hearts and Pluripotent Stem Cell–Derived Cardiomyocytes

A Novel Circular RNA circITGa9 Predominantly Generated in Human Heart Disease Induces Cardiac Remodeling and Fibrosis

CircRNA DICAR as a novel endogenous regulator for diabetic cardiomyopathy and diabetic pyroptosis of cardiomyocytes

Single-cell RNA-seq of heart reveals intercellular communication drivers of myocardial fibrosis in diabetic cardiomyopathy

Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4

Circ_0123996 promotes cell proliferation and fibrosis in mouse mesangial cells through sponging miR-149-5p and inducing Bach1 expression

Genome Wide Microarray Profiling Identified Differentially Expressed Circulating Biomarkers Associated with Early Development of Diabetic Cardiomyopathy